Display Settings:

Format

Send to:

Choose Destination
    AIDS. 2008 May 11;22(8):989-90.

    Is there a role for etravirine in patients with Nonnucleoside reverse transcriptase inhibitor resistance?

    Source

    St. Stephens Centre, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.

    Erratum in

    • AIDS. 2008 Sep 12;22(14):i.

    Abstract

    Etravirine is a next generation nonnucleoside reverse transcriptase inhibitor with activity against nonnucleoside reverse transcriptase inhibitor resistant HIV-1 virus. Susceptibility and virological response to etravirine is dependent on the type and number of nonnucleoside reverse transcriptase inhibitor resistance-associated mutations. We examined the predicted susceptibility of etravirine in patients experiencing virological failure secondary to nonnucleoside reverse transcriptase inhibitor resistance in our patient cohort.

    PMID:
    18453859
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk